Supporting the myasthenia gravis community through innovation, education, and research
argenx is a global immunology company focused on developing innovative therapies for people living with severe autoimmune diseases, including myasthenia gravis. Conquer MG is proud to partner with argenx in support of the MG community.
Through ongoing research, clinical trials, and patient-focused initiatives, argenx is working to better understand myasthenia gravis and improve treatment options for those affected. Their commitment to science and patient care helps advance meaningful progress in the MG space.
argenx also provides educational resources to help patients and caregivers better understand MG, its symptoms, and the treatment journey, supporting more informed conversations with healthcare providers.
Learn more about argenx’s work in myasthenia gravis and available resources by visiting their website here.
Patient Resources
Clinical Trials: Explore ongoing clinical trials for MG.
News and Press Releases
Conquer MG is sponsored in part by argenx. The resources on this page are not created or owned by Conquer MG. Sharing these resources does not imply endorsement of specific treatments.
